Hyponatremia in oncology is a negative prognosis factor because this occurs due to syndrome of inappropriate antidiuretic hormone (SIADH), causing excessive production of arginine vasopressin by tumors or anticancer effects. This evidence concerns the gene AVP and inappropriate ADH syndrome.